Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.Ayelet Snir, Elias Toubi, Gleb Slobodin et al.|PubMed|2011Cited by 48
FRI0205 Clues to systemic sclerosis sine sclerodermaInger L. Rosner, D Yeshurun, Gleb Slobodin et al.|Annals of the Rheumatic Diseases|2001Cited by 0